
Loading, please wait...

Loading, please wait...

Ferroptosis is a distinct form of regulated cell death. It fundamentally relies on the accumulation of lipid peroxides that damage cell membranes. Researchers have recently identified a breakthrough pathway involving the release of mitochondrial DNA in ferroptosis. While mitochondrial swelling remains a hallmark of this process, the specific signaling consequences were previously unclear. This new study highlights how mitochondria serve as more than just energy factories during cell death.
The study found that the opening of the mitochondrial permeability transition pore (mPTP) is essential for ferroptosis activation. This opening depends on Cyclophilin D (CypD). Specifically, the mPTP allows oxidized mitochondrial DNAs (mtDNAs) to escape into the cytosol. Once released, these oxidized mtDNAs function as crucial messengers. They activate the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway. Consequently, this activation promotes cell death by triggering a process known as ferrotinophagy. Therefore, the mPTP acts as a gatekeeper for inflammatory and death-inducing signals within the cell.
Furthermore, these findings offer significant potential for cancer treatment. The research demonstrates that inhibiting mtDNA repair mechanisms makes cells more sensitive to ferroptosis. This sensitivity creates a synergistic effect when combined with traditional ferroptosis inducers. In mouse xenograft models, this combination effectively suppressed tumor growth. Moreover, understanding this pathway provides a fundamental framework for developing new therapeutic strategies. Targeting the mPTP or the cGAS-STING axis could specifically enhance the efficacy of treatments against resistant tumors.
Cyclophilin D (CypD) acts as a primary regulator for the opening of the mitochondrial permeability transition pore (mPTP). In the context of ferroptosis, CypD-dependent mPTP opening is necessary for mitochondrial swelling and the release of oxidized mtDNA into the cytoplasm.
When oxidized mtDNA enters the cytosol, it activates the cGAS-STING pathway. This activation promotes ferrotinophagy, which accelerates the ferroptotic process. By driving this regulated cell death, the pathway helps suppress tumorigenesis and improves sensitivity to cancer therapies.
Yes. Inhibiting the repair of mitochondrial DNA increases the accumulation of damaged DNA. This elevates the levels of oxidized mtDNA available for release, thereby sensitizing cancer cells to ferroptosis-inducing drugs and slowing tumor progression.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Zhou H et al. CypD Dependent mPTP Opening Is Crucial for Oxidized Mitochondrial DNA Release in Ferroptosis. Adv Sci (Weinh). 2026 Feb 17. doi: 10.1002/advs.202502239. PMID: 41700459.
Mao C et al. The role of cGAS-STING signaling in ferroptosis. Cell Death Dis. 2022;13(10):859.
Stockwell BR. Ferroptosis: Death by Lipid Peroxidation. Chem Rev. 2017;117(17):11320-11358.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that CypD-dependent mPTP opening releases oxidized mtDNA to trigger ferroptosis, offering a novel target for oncology treatments....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today